US Nurse Tests Positive Over A Week After Receiving Pfizer Vaccine

Katie Ramirez
December 31, 2020

"Protecting the health and safety of Canadians is a top priority".

Mr Johnson said the public may need to carry on with "basic disciplines" such as hand-washing and wearing masks "for a while after".

Despite a slow start to US vaccinations, there was good news overseas this week as the United Kingdom gave emergency-use authorization to the COVID-19 vaccine produced by AstraZeneca and the University of Oxford.

When will the vaccinations start?

Britain is the first country in the world to approve the vaccine, which is cheaper to produce and easier to store and transport than the Pfizer-BioNTech jab.

"Everyone will still receive their second dose and this will be within 12 weeks of their first".

Why did the United Kingdom order more doses of this vaccine? That group, by error initially, received a half dose followed by a full dose.

The transition from early phase to late phase of a small molecule program plays a pivotal role in determining a program's ultimate success.

India likely to have COVID-19 vaccine within days: AIIMS Director
Poonawalla said that there were no concerns regarding the vaccine candidate and that drug regulators were evaluating the data. SII would supply the vaccine to both the government and the private sector players with different costing structures.

The U.K. also reported Wednesday that another 981 people with the coronavirus had died.

The government said it would also not recommend one vaccine over another for different cohorts of the population, even though data on the Oxford/AstraZeneca vaccine's efficacy in older people is now limited.

The protection afforded by a vaccine gives us real hope that we can see the end of the pandemic.

What's more, "effectiveness was high, up to 80%, when there was a three month interval between first and second doses, which is the reason for our recommendation", Pirmohamed added. The effort, called COVAX, has secured at least 100 million doses of the vaccine. Meanwhile, the company is continuing to work with global partners to build out manufacturing capacity for up to 3 billion doses globally in 2021 on a rolling basis, it says.

While AZ's vaccine efficacy may appear slightly lackluster, the company's shot could boast a distribution and storage edge over its competitors.

The vaccine developed by Oxford University and drugmaker AstraZeneca is expected to be relied on in many countries because of its low cost and the fact that it can be kept in refrigerators rather than at the ultra-cold or freezer temperatures some other vaccines require.

Health Secretary Matt Hancock said that at midnight the government's top infection-warning level, Tier 4, would be expanded beyond London and the southeast to cover large swaths of central, northern and southwest England, including the major cities of Manchester and Birmingham.

Other reports by

Discuss This Article

FOLLOW OUR NEWSPAPER